Cytokinetics

CYTK

Cytokinetics
$8.08 $0.13 1.6%
BATS BZX Real Time Price as of April 18, 2019, 4:30 p.m. View Interactive CYTK Charts

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

News & Analysis: Cytokinetics

All

Market Moves

Earnings







Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.




Why Cytokinetics Inc. Shares Were Mauled

Cytokinetics reported disappointing midstage results for tirasemtiv, its experimental Lou Gehrig's disease drug. Is this dip a buying opportunity or your cue to stay far away?


Interactive Chart